Updated August 28 at 4:28pm
Biotechnology
43 results total, viewing 21 - 30
Nabsys Inc. has named Tony Shuber vice president and chief scientific officer in its latest move toward bringing its genome-mapping products to market. more
MultiCell Technologies Inc. has been issued a U.S. patent for drug compositions and platform technologies, which are designed treat virus infections and cancer. more
The Champlin Foundations awarded the University of Rhode Island three grants totaling $421,795 to purchase high-tech equipment to advance education and student learning. more
Amgen Inc. won U.S. approval for its powerful cholesterol-lowering drug Repatha for certain patients, making it the second in a new class of treatments to come to market. more
The recent change in leadership at IlluminOss Medical, a commercial stage medical device company focused on minimally invasive orthopedic fracture repair, reflects its changing direction, according to those familiar with the company. more
Tivorsan Pharmaceuticals Inc. has named James E. Connolly CEO. The biotechnology company, which focuses on treating Duchenne Muscular Dystrophy and other neuromuscular disorders, also said that Connolly will serve as a member of its board. more
An investor in two large Bay State health care companies involved in separate mergers said he doesn’t expect the U.S. Treasury’s recently announced measures aimed at cracking down on corporate tax inversions to derail those plans, the Boston Business Journal reported. more
The Spectranetics Corp. will acquire Covidien PLC’s Stellarex drug-coated angioplasty balloon platform for $30 million. more
The Top 5 Biotechnology & Life Sciences Companies, ranked by number of local employees. more
Moderna Therapeutics has announced another record venture capital investment: $450 million. more
« Prev | 1 | 2 | 3 | 4 | 5 Next »